4/A//SEC Filing
Crystal Adam 4/A
Accession 0001209191-22-036712
CIK 0001662579other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:45 PM ET
Size
5.1 KB
Accession
0001209191-22-036712
Insider Transaction Report
Form 4/AAmended
Crystal Adam
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2022-05-26$7.01/sh−1,102$7,725→ 17,648 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of performance restricted stock units and does not represent a sale by the Reporting Person.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001825445
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:45 PM ET
- Size
- 5.1 KB